Flora Growth Corp. FLGC
Feb 2, 2026, 9:30 AM EST
52-week range unavailable
- YTD
- +24.44%
- 1 year
- -66.71%
- Market cap
- 18.31M
- Revenue (ttm)
- 69.01M
- Profit margin
- -21.55%
- Shares out
- 17.28M
- Forward P/E
- 3.12
- YTD return
- +24.44%
- 1-year return
- -66.71%
- Volume
- 107.94K
- Open
- 10.20
- Previous close
- 7.79
- Day's range
- 7.52 – 11.00
- Beta
- 1.86
- Price target
- 4.00 (-48.7%)
- Earnings date
- Aug 12, 2024
Key statistics
- Enterprise value
- 17.93M
- PEG ratio
- 0.00
- Price / sales
- 0.27
- Price / book
- 1.47
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- -26.90%
- Free cash flow
- 1.40M
- Total cash
- 6.13M
- Total debt
- 5.61M
- Return on equity
- -135.37%
- Short % of float
- 7.75%
- 50-day average
- 1.50
- 200-day average
- 1.35
Analyst view
- Strong buy1
- Buy1
- Hold1
- Sell0
- Strong sell0
Next earnings
Aug 12, 2024
Expected Aug 12, 2024. Consensus EPS estimate -0.11.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | -0.09 | -0.24 | -0.15 | -166.67% |
| Aug 12, 2024 | Jun 1, 2024 | -0.05 | -0.22 | -0.17 | -340.00% |
| Aug 12, 2024 | Jun 1, 2024 | -0.05 | — | — | — |
| May 14, 2024 | Mar 1, 2024 | -0.22 | — | — | — |
| May 14, 2024 | Mar 1, 2024 | -0.22 | -0.28 | -0.06 | -27.27% |
| Mar 29, 2024 | Dec 1, 2023 | -0.14 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 25, 2024 | Aegis Capital | init | — | Buy |
| Aug 15, 2024 | Alliance Global Partners | down | Buy | Neutral |
| May 16, 2024 | Roth MKM | reit | Buy | Buy |
| Apr 3, 2024 | Roth MKM | main | Buy | Buy |
About Flora Growth Corp.
Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- floragrowth.com
News
Flora Growth (NASDAQ:FLGC) and Veru (NASDAQ:VERU) Financial Review 
Flora Growth Corp. Announces Withdrawal of Proposed Public Offering 
Why F5 Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket 
Flora Growth Corp. Announces Proposed Underwritten Public Offering 
Flora Growth Corp. Announces Name Change to ZeroStack Corp., Furthering Its Strategy as an AI-Focused Asset Management Company 
Flora Growth Announces Results of 2025 Special Meeting of Shareholders 
'Trump's Marijuana Executive Order Details Leaked Ahead Of Announcement, Including CBD And Hemp Provisions'- Marijuana Moment 
White House Considers Cannabis Reclassification, Stops Short Of Legalization: Stocks To Watch 
'Trump to sign executive order reclassifying marijuana: Officials' -ABC Report 
Why Did Flora Growth Corp (FLGC) Surge 6% In After-Hours Trading?
Your note
Sign in to keep a note on FLGC — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DORF SAMMY | Officer and Director | Stock Award(Grant) | Dec 12, 2024 | 250,000 |
| LESLIE JOHN TIMOTHY | Director | Stock Award(Grant) | Mar 16, 2023 | 138,574 |
| MASTRONARDI MARC | Director | Stock Award(Grant) | Mar 16, 2023 | 160,000 |
| RAKINE HUSSEIN | Chief Executive Officer | Stock Award(Grant) | Apr 13, 2023 | 8,617,020 |
| STARKE CLIFFORD A | Chief Executive Officer | Stock Award(Grant) | Dec 12, 2024 | 2,246,900 |
| TAYLOR KEVIN ROBERT | Chairman of the Board | Stock Award(Grant) | Nov 14, 2023 | 138,736 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Renaissance Technologies, LLC | 0.91% | 131,143 | 139.01K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.74% | 106,221 | 112.59K | Sep 29, 2024 |
| Vanguard Group Inc | 0.62% | 88,780 | 94.11K | Sep 29, 2024 |
| Citadel Advisors Llc | 0.15% | 21,484 | 22.77K | Sep 29, 2024 |
| Xtx Topco Ltd | 0.13% | 18,070 | 19.15K | Sep 29, 2024 |
| Northern Trust Corporation | 0.11% | 16,415 | 17.40K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.62% | 88,780 | 94.11K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.43% | 62,165 | 65.89K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.14% | 20,041 | 21.24K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.10% | 15,122 | 16.03K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.02% | 3,029 | 3.21K | Oct 30, 2024 |